A carregar...
Monobodies as possible next-generation protein therapeutics – a perspective
Over the past two decades, hundreds of new somatic mutations have been identified in tumours, and a few dozen novel cancer therapeutics that selectively target these mutated oncoproteins have entered clinical practice. This development has resulted in clinical breakthroughs for a few tumour types, b...
Na minha lista:
| Publicado no: | Swiss Med Wkly |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7316567/ https://ncbi.nlm.nih.gov/pubmed/29185244 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4414/smw.2017.14545 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|